{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:48:51Z","timestamp":1788432531073,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijrobp.2010.07.024","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T04:21:45Z","timestamp":1286425305000},"page":"1081-1090","source":"Crossref","is-referenced-by-count":74,"title":["Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas"],"prefix":"10.1016","volume":"81","author":[{"given":"Sam S.","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan G.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash R.","family":"Kambadakone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Rothrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Petur","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dreyfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ancukiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant V.","family":"Sahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"DeLaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.07.024_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00001622-200207000-00006","article-title":"Retroperitoneal sarcomas: Combined modality treatment approaches","volume":"14","author":"Pisters","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1994.12.6.1150","article-title":"A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk","volume":"12","author":"Pisters","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1245\/ASO.2006.05.035","article-title":"Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma","volume":"13","author":"Pawlik","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1245\/s10434-010-0935-1","article-title":"Proton-beam, intensity-modulated, and\/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas","volume":"17","author":"Yoon","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1634\/theoncologist.2009-0007","article-title":"Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?","volume":"14","author":"Schuetze","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jss.2006.01.023","article-title":"Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression","volume":"135","author":"Yoon","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib8","first-page":"39","article-title":"Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts","volume":"61","author":"Kozin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib9","first-page":"1957","article-title":"Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction","volume":"9","author":"Wachsberger","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib10","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2010.07.024_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1634\/theoncologist.9-suppl_1-27","article-title":"Expanding the clinical development of bevacizumab","volume":"9","author":"Chen","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib13","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.2008.21.1771","article-title":"Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: A multidisciplinary phase II study","volume":"27","author":"Willett","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.rcl.2008.11.003","article-title":"Body perfusion CT: Technique, clinical applications, and advances","volume":"47","author":"Kambadakone","year":"2009","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiol.2343040286","article-title":"Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations","volume":"234","author":"Sahani","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nprot.2007.111","article-title":"A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood","volume":"2","author":"Duda","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib17","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1158\/0008-5472.CAN-04-4078","article-title":"Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A","volume":"65","author":"Detwiller","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ccr.2008.02.018","article-title":"Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth","volume":"13","author":"Ryeom","year":"2008","journal-title":"Cancer Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2010.07.024_bib19","first-page":"117","article-title":"Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma","volume":"16","author":"Canter","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib20","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial","volume":"359","author":"O\u2019Sullivan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2512081403","article-title":"High-grade soft-tissue sarcomas: Tumor response assessment\u2014Pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria","volume":"251","author":"Stacchiotti","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib22","unstructured":"Dicker AP, Anne R, Bonanni R, et al. Phase I trial results of recombinant human angiostatin protein (rhA) and external beam radiation therapy (EBRT) [Abstract]. Presented at the 38th Annual Meeting of the American Society for Clinical Oncology, 2002."},{"key":"10.1016\/j.ijrobp.2010.07.024_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijrobp.2008.10.043","article-title":"Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas","volume":"75","author":"Gutin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib24","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1158\/1078-0432.CCR-09-0688","article-title":"Phase I\/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: Vasculature-independent radiosensitizing effect of bevacizumab","volume":"15","author":"Koukourakis","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2005.03.6780","article-title":"Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer","volume":"24","author":"Crane","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2007.04.001","article-title":"Gene expression profiling in sarcomas","volume":"63","author":"Tschoep","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib27","first-page":"5859","article-title":"Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray","volume":"62","author":"Nagayama","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.07.024_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrclinonc.2009.63","article-title":"Biomarkers of response and resistance to antiangiogenic therapy","volume":"6","author":"Jain","year":"2009","journal-title":"Nat Rev Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610009557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610009557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T10:56:04Z","timestamp":1544180164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610009557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0360301610009557"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.07.024","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}